Dudediligence.

CAMP4 Therapeutics Corporation

CAMPNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$652,000Dec ’24$858,000Mar ’25$1.5MJun ’25$795,000Sep ’25$348,000Dec ’25$1.3MMar ’26$1.8MJun ’26
Net income, by quarter
−$13.5MSep ’24−$13.3MDec ’24−$12.4MMar ’25−$12.6MJun ’25−$15.1MSep ’25−$40.3MDec ’25−$18.3MMar ’26−$33.5MJun ’26
Fiscal years, by the month each ended
LineDec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$350,000$652,000$3.5M
Operating incomenone on file−$51.9M−$53.1M−$52.6M
Net incomenone on file−$49.3M−$51.8M−$80.4M
Operating cash flownone on file−$44.2M−$45.6M−$29.6M
Free cash flownone on file−$44.8M−$46.0M−$29.8M
Cash$84.5M$38.4M$64.0M$109.5M
Shares outstandingnone on file460.7K20.1M51.9M